AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Acutus Medical, Inc.

$0 -$0.00 (-50.00%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0$0
Year Range
$0$0.01
Market Cap
2.99K
AVG Volume
17.65K
Trailing/Forward PE
-0/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
2026-11-13
Primary Exchange
Other OTCUS
Revenue (USD)
-10M-5M05M10M22 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q324 Q4
AFIB Revenue (USD) by quarter
PeriodRevenue (USD)
24 Q47.14M
24 Q35.27M
24 Q24.13M
24 Q13.62M
23 Q4-7.53M
23 Q35.24M
23 Q25.29M
23 Q11.24M
22 Q44.96M
22 Q33.64M
Net Income (USD)
-40M-20M020M22 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q324 Q4
AFIB Net Income (USD) by quarter
PeriodNet Income (USD)
24 Q4-1.41M
24 Q3-5.61M
24 Q2-914K
24 Q1-1.62M
23 Q4-33.77M
23 Q3-13.24M
23 Q2-18.35M
23 Q1-16.32M
22 Q415.11M
22 Q3-20.39M
Operating Income (USD)
-40M-20M020M40M22 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q324 Q4
AFIB Operating Income (USD) by quarter
PeriodOperating Income (USD)
24 Q4-272K
24 Q3489K
24 Q2301K
24 Q1-575K
23 Q435.69M
23 Q3-12.94M
23 Q2-17.17M
23 Q1-5.27M
22 Q416.82M
22 Q3-20.46M
EBITDA (USD)
-20M020M40M22 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q324 Q4
AFIB EBITDA (USD) by quarter
PeriodEBITDA (USD)
24 Q4322K
24 Q3836K
24 Q21.4M
24 Q1-313K
23 Q432.42M
23 Q3-10.45M
23 Q2-16.63M
23 Q1-2.72M
22 Q418.16M
22 Q3-17.6M
Cash Flows (USD)
-30M-20M-10M022 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q324 Q4
AFIB Cash Flows (USD) by quarter
PeriodCash Flows (USD)
24 Q4-4.02M
24 Q3-3.7M
24 Q2-7.01M
24 Q1-17.03M
23 Q4-16.84M
23 Q3-14.42M
23 Q2-15.33M
23 Q1-15.75M
22 Q4-14.49M
22 Q3-24.59M
EPS (USD)
-1.5-1-0.500.522 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q324 Q4
AFIB EPS (USD) by quarter
PeriodEPS (USD)
24 Q4-0.05
24 Q3-0.19
24 Q2-0.03
24 Q1-0.05
23 Q4-1.16
23 Q3-0.45
23 Q2-0.63
23 Q1-0.57
22 Q40.41
22 Q3-0.72
Expenses (USD)
-40M-20M020MR&DSG&ACapex22 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q324 Q4
AFIB Expenses (USD) by quarter
PeriodExpenses (USD)
24 Q42.52M
24 Q32.32M
24 Q22.26M
24 Q13.44M
23 Q4-27.62M
23 Q312.64M
23 Q216.84M
23 Q15.43M
22 Q417.23M
22 Q316.38M
Cash & Debt (USD)
020M40M60M80MCashLong Term DebtShort Term Debt22 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q324 Q4
AFIB Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
24 Q414.02M
24 Q312.6M
24 Q213.33M
24 Q119.95M
23 Q422.4M
23 Q338.48M
23 Q254.52M
23 Q169.58M
22 Q470.45M
22 Q366.3M
Debt ratios
-5051022 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q324 Q4
AFIB Debt ratios by quarter
PeriodDebt ratios
24 Q49.67
24 Q30.68
24 Q20.98
24 Q13.69
23 Q46.13
23 Q3-0.04
23 Q20.84
23 Q1-4.57
22 Q41.16
22 Q30.37
Margins
-100%-50%0%50%22 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q324 Q4
AFIB Margins by quarter
PeriodMargins
24 Q414.08%
24 Q37.06%
24 Q2-8.31%
24 Q1-0.83%
23 Q4-74.54%
23 Q3-64.09%
23 Q2-52.45%
23 Q1-69.97%
22 Q4-67.69%
22 Q3-90.75%
Return on Capital
-1000%0%1000%2000%3000%4000%22 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q324 Q4
AFIB Return on Capital by quarter
PeriodReturn on Capital
24 Q412.13%
24 Q354.44%
24 Q219.02%
24 Q140.3%
23 Q43841.3%
23 Q3-41.75%
23 Q2-41.94%
23 Q1-26.98%
22 Q420.14%
22 Q3-35.29%
Shares Outstanding
010M20M30M22 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q324 Q4
AFIB Shares Outstanding by quarter
PeriodShares Outstanding
24 Q429.77M
24 Q329.8M
24 Q229.72M
24 Q129.69M
23 Q429.26M
23 Q329.26M
23 Q229.04M
23 Q128.76M
22 Q428.47M
22 Q328.36M
Book Value Per Share (USD)
-1012322 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q324 Q4
AFIB Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
24 Q4-0.39
24 Q3-0.35
24 Q2-0.16
24 Q1-0.14
23 Q4-0.03
23 Q31.08
23 Q21.51
23 Q12.1
22 Q42.63
22 Q32.04
Total Assets (USD)
050M100M150M22 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q324 Q4
AFIB Total Assets (USD) by quarter
PeriodTotal Assets (USD)
24 Q428.65M
24 Q332.17M
24 Q235.47M
24 Q141.67M
23 Q453.96M
23 Q384.73M
23 Q2100.3M
23 Q1116M
22 Q4133.44M
22 Q3114.63M
Employee Count
010020030040020202021202220232024
AFIB Employee Count by quarter
PeriodEmployee Count
202485
2023230
2022225
2021338
2020291
Free Cash Flow Yield
-150000000%-100000000%-50000000%0%med -213462.63%Jan 25May 25Sep 25Jan 26May 26Sep 26
AFIB Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-1067313.16%
Sep 26-1067313.19%
Aug 26-1067313.19%
Aug 26-1067313.19%
Aug 26-106731315.5%
Aug 26-106731315.5%
Jul 26-1067313.19%
Jul 26-1067313.19%
Jul 26-1067313.19%
Jul 26-1067313.19%
Jul 26-1067313.16%
Jun 26-1067313.19%
Jun 26-106731315.5%
Jun 26-106731315.5%
Jun 26-533656.59%
May 26-1067313.16%
May 26-1067313.16%
May 26-1067313.19%
May 26-355771.05%
May 26-355771.05%
Apr 26-106731315.5%
Apr 26-533656.58%
Apr 26-533656.58%
Apr 26-1067313.16%
Mar 26-1067313.16%
Mar 26-355771.04%
Mar 26-106731315.5%
Mar 26-213462.62%
Feb 26-533656.58%
Feb 26-533656.58%
Feb 26-533656.59%
Feb 26-533656.58%
Jan 26-533656.59%
Jan 26-533656.58%
Jan 26-533656.59%
Jan 26-533656.58%
Jan 26-533656.58%
Dec 25-1067313.16%
Dec 25-1067313.16%
Dec 25-355771.05%
Dec 25-53365.66%
Nov 25-106731.32%
Nov 25-1067313.16%
Nov 25-213462.63%
Nov 25-355771.05%
Oct 25-355771.05%
Oct 25-106731.32%
Oct 25-213462.63%
Oct 25-53365.66%
Oct 25-213462.63%
Sep 25-118590.35%
Sep 25-118590.35%
Sep 25-106731.32%
Sep 25-266828.29%
Aug 25-133414.14%
Aug 25-213462.63%
Aug 25-213462.63%
Aug 25-213462.63%
Aug 25-213462.62%
Jul 25-213462.63%
Jul 25-79060.23%
Jul 25-53365.66%
Jul 25-53365.66%
Jun 25-59295.18%
Jun 25-35577.11%
Jun 25-53365.66%
Jun 25-53365.66%
May 25-10673.13%
May 25-9702.85%
May 25-3442.95%
May 25-3557.71%
May 25-2736.7%
Apr 25-2603.2%
Apr 25-2482.12%
Apr 25-2964.76%
Apr 25-2736.7%
Mar 25-2270.88%
Mar 25-3252.78%
Mar 25-2992.56%
Mar 25-2770.89%
Feb 25-3252.78%
Feb 25-2770.89%
Feb 25-2992.56%
Feb 25-2536.07%
Jan 25-2493.8%
Jan 25-2604.49%
Jan 25-2485.51%
Jan 25-2409.47%
Jan 25-3252.78%
Dec 24-2720.51%
Dec 24-2877.46%
Dec 24-2337.94%
Dec 24-2107.44%
Nov 24-2489.65%
Nov 24-2275.71%
Nov 24-2375.05%
Nov 24-2268.05%
Nov 24-1170.25%
Oct 24-1170.99%
Oct 24-1270.54%
Price to Sales
00.250.50.751med 0Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
AFIB Price to Sales by quarter
PeriodPrice to Sales
Sep 260
Sep 260
Aug 260
Aug 260
Aug 260
Aug 260
Jul 260
Jul 260
Jul 260
Jul 260
Jul 260
Jun 260
Jun 260
Jun 260
Jun 260
May 260
May 260
May 260
May 260
May 260
Apr 260
Apr 260
Apr 260
Apr 260
Mar 260
Mar 260
Mar 260
Mar 260
Feb 260
Feb 260
Feb 260
Feb 260
Jan 260
Jan 260
Jan 260
Jan 260
Jan 260
Dec 250
Dec 250
Dec 250
Dec 250
Nov 250
Nov 250
Nov 250
Nov 250
Oct 250
Oct 250
Oct 250
Oct 250
Oct 250
Sep 250
Sep 250
Sep 250
Sep 250
Aug 250
Aug 250
Aug 250
Aug 250
Aug 250
Jul 250
Jul 250
Jul 250
Jul 250
Jun 250
Jun 250
Jun 250
Jun 250
May 250.01
May 250.02
May 250.05
May 250.04
May 250.06
Apr 250.06
Apr 250.06
Apr 250.05
Apr 250.06
Mar 250.07
Mar 250.25
Mar 250.27
Mar 250.29
Feb 250.25
Feb 250.29
Feb 250.27
Feb 250.32
Jan 250.33
Jan 250.31
Jan 250.33
Jan 250.34
Jan 250.25
Dec 240.3
Dec 240.28
Dec 240.35
Dec 240.39
Nov 240.33
Nov 240.36
Nov 240.34
Nov 240.45
Nov 240.87
Oct 240.87
Oct 240.8
EV/EBITDA
02.557.51012.5med 9.67Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
AFIB EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 269.67
Sep 269.67
Aug 269.67
Aug 269.67
Aug 269.67
Aug 269.67
Jul 269.67
Jul 269.67
Jul 269.67
Jul 269.67
Jul 269.67
Jun 269.67
Jun 269.67
Jun 269.67
Jun 269.67
May 269.67
May 269.67
May 269.67
May 269.67
May 269.67
Apr 269.67
Apr 269.67
Apr 269.67
Apr 269.67
Mar 269.67
Mar 269.67
Mar 269.67
Mar 269.68
Feb 269.67
Feb 269.67
Feb 269.67
Feb 269.67
Jan 269.67
Jan 269.67
Jan 269.67
Jan 269.67
Jan 269.67
Dec 259.67
Dec 259.67
Dec 259.67
Dec 259.7
Nov 259.68
Nov 259.67
Nov 259.68
Nov 259.67
Oct 259.67
Oct 259.68
Oct 259.68
Oct 259.7
Oct 259.68
Sep 259.68
Sep 259.68
Sep 259.68
Sep 259.67
Aug 259.68
Aug 259.68
Aug 259.68
Aug 259.68
Aug 259.68
Jul 259.68
Jul 259.69
Jul 259.7
Jul 259.7
Jun 259.69
Jun 259.71
Jun 259.7
Jun 259.7
May 259.8
May 259.81
May 2510.08
May 2510.07
May 2510.18
Apr 2510.21
Apr 2510.24
Apr 2510.15
Apr 2510.18
Mar 2510.29
Mar 250.71
Mar 250.72
Mar 250.72
Feb 250.71
Feb 250.72
Feb 250.72
Feb 250.73
Jan 250.73
Jan 250.72
Jan 250.73
Jan 250.73
Jan 250.71
Dec 240.72
Dec 240.72
Dec 240.73
Dec 240.74
Nov 240.73
Nov 240.73
Nov 240.73
Nov 241.08
Nov 241.18
Oct 241.18
Oct 241.17
Price to Book
00.20.40.60.81med 0.34Jul 22Oct 22Feb 23May 23Sep 23Dec 23Mar 24
AFIB Price to Book by quarter
PeriodPrice to Book
Mar 240.17
Mar 240.17
Mar 240.18
Mar 240.17
Mar 240.19
Feb 240.2
Feb 240.18
Feb 240.17
Feb 240.16
Jan 240.22
Jan 240.16
Jan 240.18
Jan 240.17
Dec 230.19
Dec 230.17
Dec 230.2
Dec 230.19
Dec 230.22
Nov 230.25
Nov 230.23
Nov 230.2
Nov 230.41
Oct 230.33
Oct 230.39
Oct 230.4
Oct 230.44
Sep 230.46
Sep 230.46
Sep 230.35
Sep 230.31
Sep 230.32
Aug 230.34
Aug 230.36
Aug 230.4
Aug 230.33
Jul 230.33
Jul 230.36
Jul 230.38
Jul 230.42
Jun 230.42
Jun 230.42
Jun 230.39
Jun 230.42
Jun 230.4
May 230.46
May 230.43
May 230.42
May 230.34
Apr 230.34
Apr 230.3
Apr 230.26
Apr 230.26
Mar 230.29
Mar 230.3
Mar 230.45
Mar 230.45
Mar 230.59
Feb 230.74
Feb 230.77
Feb 230.75
Feb 230.88
Jan 230.78
Jan 230.74
Jan 230.6
Jan 230.66
Dec 220.56
Dec 220.52
Dec 220.45
Dec 220.45
Dec 220.46
Nov 220.34
Nov 220.32
Nov 220.35
Nov 220.34
Oct 220.27
Oct 220.31
Oct 220.28
Oct 220.27
Sep 220.33
Sep 220.32
Sep 220.43
Sep 220.4
Sep 220.38
Aug 220.48
Aug 220.51
Aug 220.61
Aug 220.64
Jul 220.64
Jul 220.65
Jul 220.46
Jul 220.35
Jul 220.33
Jun 220.22
Jun 220.2
Jun 220.26
Jun 220.25
May 220.29
May 220.32
May 220.36
May 220.28
Acutus Medical, Inc.
AFIB
Stockpicker

Video analysis: AFIB

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: AFIB

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.